PMC:7386875 / 1334-1588
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T22","span":{"begin":7,"end":23},"obj":"Disease"},{"id":"T23","span":{"begin":62,"end":70},"obj":"Disease"},{"id":"T24","span":{"begin":158,"end":166},"obj":"Disease"},{"id":"T25","span":{"begin":190,"end":200},"obj":"Disease"}],"attributes":[{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0002049"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0000831"}],"text":"r) and thrombocytopenia have emerged as prognostic markers in COVID-19. Given thrombotic complications are central determinants of the high mortality rate in COVID-19, strategies to prevent thrombosis are of critical importance. Several antithrombotic dr"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T6","span":{"begin":7,"end":23},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0001873"}],"text":"r) and thrombocytopenia have emerged as prognostic markers in COVID-19. Given thrombotic complications are central determinants of the high mortality rate in COVID-19, strategies to prevent thrombosis are of critical importance. Several antithrombotic dr"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T9","span":{"begin":72,"end":228},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"r) and thrombocytopenia have emerged as prognostic markers in COVID-19. Given thrombotic complications are central determinants of the high mortality rate in COVID-19, strategies to prevent thrombosis are of critical importance. Several antithrombotic dr"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"79","span":{"begin":7,"end":23},"obj":"Disease"},{"id":"80","span":{"begin":62,"end":70},"obj":"Disease"},{"id":"81","span":{"begin":78,"end":102},"obj":"Disease"},{"id":"82","span":{"begin":140,"end":149},"obj":"Disease"},{"id":"83","span":{"begin":158,"end":166},"obj":"Disease"},{"id":"84","span":{"begin":190,"end":200},"obj":"Disease"}],"attributes":[{"id":"A79","pred":"tao:has_database_id","subj":"79","obj":"MESH:D013921"},{"id":"A80","pred":"tao:has_database_id","subj":"80","obj":"MESH:C000657245"},{"id":"A81","pred":"tao:has_database_id","subj":"81","obj":"MESH:D013927"},{"id":"A82","pred":"tao:has_database_id","subj":"82","obj":"MESH:D003643"},{"id":"A83","pred":"tao:has_database_id","subj":"83","obj":"MESH:C000657245"},{"id":"A84","pred":"tao:has_database_id","subj":"84","obj":"MESH:D013927"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"r) and thrombocytopenia have emerged as prognostic markers in COVID-19. Given thrombotic complications are central determinants of the high mortality rate in COVID-19, strategies to prevent thrombosis are of critical importance. Several antithrombotic dr"}